
Gary Jackson
Supervisory Patent Examiner (ID: 5661, Phone: (571)272-4697 , Office: P/3769 )
| Most Active Art Unit | 3731 |
| Art Unit(s) | 3304, 3308, 4158, 3727, 3309, 2899, 3734, 3792, 3731, 3407, 3769 |
| Total Applications | 2094 |
| Issued Applications | 1632 |
| Pending Applications | 166 |
| Abandoned Applications | 295 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 322721
[patent_doc_number] => 07517954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'RGD-enriched gelatine-like proteins with enhanced cell binding'
[patent_app_type] => utility
[patent_app_number] => 10/550786
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7401
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550786 | RGD-enriched gelatine-like proteins with enhanced cell binding | Mar 25, 2004 | Issued |
Array
(
[id] => 7605369
[patent_doc_number] => 07115560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Methods for modulating gastric secretion using prokineticin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/811328
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13947
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115560.pdf
[firstpage_image] =>[orig_patent_app_number] => 10811328
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/811328 | Methods for modulating gastric secretion using prokineticin receptor antagonists | Mar 24, 2004 | Issued |
Array
(
[id] => 7446825
[patent_doc_number] => 20040186055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'PsiepsilonRACK peptide composition and method for protection against tissue damage due to ischemia'
[patent_app_type] => new
[patent_app_number] => 10/807553
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7863
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186055.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807553 | ΨεRACK peptide composition and method for protection against tissue damage due to ischemia | Mar 21, 2004 | Issued |
Array
(
[id] => 5056871
[patent_doc_number] => 20070059793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Nogo receptor binding protein'
[patent_app_type] => utility
[patent_app_number] => 10/553685
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18510
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059793.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553685
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553685 | Nogo receptor binding protein | Mar 16, 2004 | Issued |
Array
(
[id] => 7061659
[patent_doc_number] => 20050004021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Novel human kunitz-type inhibitors and methods relating thereto'
[patent_app_type] => utility
[patent_app_number] => 10/800057
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13718
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800057 | Novel human kunitz-type inhibitors and methods relating thereto | Mar 11, 2004 | Abandoned |
Array
(
[id] => 6944695
[patent_doc_number] => 20050196744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Method of screening cocaine antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/794375
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7758
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794375
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794375 | Method of screening cocaine antagonists | Mar 4, 2004 | Abandoned |
Array
(
[id] => 7409770
[patent_doc_number] => 20040176303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Conopeptides and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/794640
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8355
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176303.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794640
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794640 | Conopeptides and methods of use | Mar 4, 2004 | Abandoned |
Array
(
[id] => 589861
[patent_doc_number] => 07439418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide'
[patent_app_type] => utility
[patent_app_number] => 10/547563
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4312
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/439/07439418.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547563 | Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide | Mar 4, 2004 | Issued |
Array
(
[id] => 899642
[patent_doc_number] => 07338781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-04
[patent_title] => 'Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/548420
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 34612
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/338/07338781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548420
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548420 | Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof | Mar 3, 2004 | Issued |
Array
(
[id] => 4432077
[patent_doc_number] => 07968512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Conjugates that contain the homeodomain of antennapedia'
[patent_app_type] => utility
[patent_app_number] => 10/789403
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 10440
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968512.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789403
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789403 | Conjugates that contain the homeodomain of antennapedia | Feb 26, 2004 | Issued |
Array
(
[id] => 7468037
[patent_doc_number] => 20040167071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Process for inactivating prions in lipoproteins'
[patent_app_type] => new
[patent_app_number] => 10/785681
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14169
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785681
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785681 | Process for inactivating prions in lipoproteins | Feb 23, 2004 | Abandoned |
Array
(
[id] => 798076
[patent_doc_number] => 07427663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-23
[patent_title] => 'Cardio myopeptidin, the production and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/567286
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 17213
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427663.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567286
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567286 | Cardio myopeptidin, the production and the use thereof | Feb 22, 2004 | Issued |
Array
(
[id] => 7432342
[patent_doc_number] => 20040209809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Shc modulation and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/782283
[patent_app_country] => US
[patent_app_date] => 2004-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15978
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10782283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/782283 | Shc modulation and uses thereof | Feb 18, 2004 | Abandoned |
Array
(
[id] => 5022773
[patent_doc_number] => 20070148739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Fusion proteins of interferon alpha muteins with improved properties'
[patent_app_type] => utility
[patent_app_number] => 10/546112
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11251
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546112
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546112 | Fusion proteins of interferon alpha muteins with improved properties | Feb 17, 2004 | Issued |
Array
(
[id] => 7215613
[patent_doc_number] => 20050054570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Albumin fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 10/775180
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 179569
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054570.pdf
[firstpage_image] =>[orig_patent_app_number] => 10775180
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/775180 | Albumin fusion proteins | Feb 10, 2004 | Issued |
Array
(
[id] => 5754606
[patent_doc_number] => 20060223755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Peptide inhibitors of toxins derived from ll-37'
[patent_app_type] => utility
[patent_app_number] => 10/543521
[patent_app_country] => US
[patent_app_date] => 2004-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9545
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223755.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543521 | Peptide inhibitors of toxins derived from LL-37 | Jan 26, 2004 | Issued |
Array
(
[id] => 7313043
[patent_doc_number] => 20040143860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Novel presenilin associated membrane protein (PAMP)and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/763502
[patent_app_country] => US
[patent_app_date] => 2004-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18496
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10763502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/763502 | Presenilin associated membrane protein (PAMP)and uses thereof | Jan 21, 2004 | Issued |
Array
(
[id] => 292180
[patent_doc_number] => 07544469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Methods and compositions for optical detection of single-stranded polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/542336
[patent_app_country] => US
[patent_app_date] => 2004-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 12514
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544469.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542336
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542336 | Methods and compositions for optical detection of single-stranded polynucleotides | Jan 11, 2004 | Issued |
Array
(
[id] => 292180
[patent_doc_number] => 07544469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Methods and compositions for optical detection of single-stranded polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/542336
[patent_app_country] => US
[patent_app_date] => 2004-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 12514
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544469.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542336
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542336 | Methods and compositions for optical detection of single-stranded polynucleotides | Jan 11, 2004 | Issued |
Array
(
[id] => 4583614
[patent_doc_number] => 07851433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-14
[patent_title] => 'Method of purifying TFPI and TFPI analogs'
[patent_app_type] => utility
[patent_app_number] => 10/753078
[patent_app_country] => US
[patent_app_date] => 2004-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 16
[patent_no_of_words] => 18689
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/851/07851433.pdf
[firstpage_image] =>[orig_patent_app_number] => 10753078
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/753078 | Method of purifying TFPI and TFPI analogs | Jan 7, 2004 | Issued |